Concepedia

Author

Ivana Vojnovic

William Harvey Research Institute

Also Known As

I VOJNOVIC, I Vojnovic, I. VOJNOVIC, I. Vojnovic, Ivana Vojnovic, Vojnovic, I

28

Publications

2.3K

Citations

14

H-Index

30

Concepts

All Affiliations

William Harvey Research InstituteQueen Mary University of LondonImperial College LondonRoyal Brompton HospitalUniversity College London
IV

About

Ivana Vojnovic is an author at William Harvey Research Institute specializing in medicine, pharmacology, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

421

2

Natural Sciences

2

2

173

3

Biochemistry

2

2

173

4

Allergy

1

1

53

5

Chemical Biology

1

1

126

Ivana Vojnovic

×

16

Publications

2.3K

Citations

14

H-Index

YearCitations

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full <i>in vitro</i> analysis

Timothy D. Warner, Francesco Giuliano, Ivana Vojnovic,

Proceedings of the National Academy of Sciences

1999

1.5K

Cellular mechanisms of acetaminophen: role of cyclo‐oxygenase

Timothy D. Warner, Ivana Vojnovic, Jane A. Mitchell

The FASEB Journal

2005

126

A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo‐oxygenase‐2 <i>in vitro</i> and <i>in vivo</i> in a substrate‐sensitive manner

Lorna Hamilton, Ivana Vojnovic, Timothy D. Warner

British Journal of Pharmacology

1999

81

Stronger inhibition by nonsteroid anti‐inflammatory drugs of cyclooxygenase‐1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events

Jane A. Mitchell, Ivana Vojnovic, Kamrul Hasan,

The FASEB Journal

2006

74

Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2

Paul C. Armstrong, N.J. TRUSS, Ferhana Y. Ali,

Journal of Thrombosis and Haemostasis

2008

69

Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle

Rosario Jiménez, Elizabeth Belcher, Shiranee Sriskandan,

Proceedings of the National Academy of Sciences

2005

56

Effects of non‐steroidal anti‐inflammatory drugs on cyclo‐oxygenase and lipoxygenase activity in whole blood from aspirin‐sensitive asthmatics vs healthy donors

Paula Gray, Timothy D. Warner, Ivana Vojnovic,

British Journal of Pharmacology

2002

53

Blockade of the purinergic P2Y <sub>12</sub> receptor greatly increases the platelet inhibitory actions of nitric oxide

Nicholas S. Kirkby, Martina H. Lundberg, Melissa V. Chan,

Proceedings of the National Academy of Sciences

2013

51

Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells

Nino Kvirkvelia, Ivana Vojnovic, Timothy D. Warner,

Clinical & Experimental Immunology

2002

50

Influence of plasma protein on the potencies of inhibitors of cyclooxygenase‐1 and ‐2

Timothy D. Warner, Ivana Vojnovic, David Bishop‐Bailey,

The FASEB Journal

2006

47

Page 1